1.02766

Copper(II) oxide

powder for analysis EMSURE® ACS

Manufacturer: Supelco

CAS Number: 1317-38-0

Synonym(S): Copper(II) oxide, Copper monoxide granulated

Select a Size

Pack Size SKU Availability Price
100 G 1.02766-100-G In Stock ₹ 23,873.42
500 G 1.02766-500-G In Stock ₹ 83,570.00
25 KG 1.02766-25-KG In Stock ₹ 25,07,230.01

1.02766 - 100 G

₹ 23,873.42

In Stock

Quantity

1

Base Price: ₹ 23,873.42

GST (18%): ₹ 4,297.216

Total Price: ₹ 28,170.636

grade

ACS reagent

Quality Level

300

product line

EMSURE®

Assay

≥99.0% (complexometric)

form

solid

potency

470 mg/kg LD50, oral (Rat)

impurities

≤0.01% Total sulfur (as SO4)≤0.02% Substances insoluble in dilute hydrochloric acid

particle size

≤160 μm (d95,laser diffraction)

pH

7 (20 °C, 50 g/L in H2O, slurry)

mp

1326 °C (decomposition)

Related Products

Img

Supelco

1.02761

powder EMPLURA®...

Img

Supelco

1.07381

for analysis EMSURE® ACS...

Img

Supelco

1.02047

for analysis EMSURE® ACS,Reag. Ph E...

Img

Supelco

1.05680

for analysis EMSURE® ACS,Reag. Ph E...

Img

Supelco

1.08849

for analysis EMSURE® ACS,Reag. Ph E...

Img

Supelco

1.02067

precipitated for analysis of silica...

Img

Supelco

1.04484

for analysis EMSURE® Reag. Ph Eur...

Img

Supelco

1.02739

for analysis EMSURE® ACS...

Description

  • Application: Impact of temperature on the physicochemical, structural and biological features of copper-silica nanocomposites.: This study investigates how temperature variations affect the properties of copper-silica nanocomposites. The research focuses on the physicochemical and structural changes that occur and their subsequent impact on biological applications. The findings provide valuable insights for the development of advanced materials with tailored properties for specific applications (Dulski et al., 2020).H(2)O(2)-assisted photoelectrocatalytic degradation of Mitoxantrone using CuO nanostructured films: Identification of by-products and toxicity.: This article explores the degradation of Mitoxantrone, a chemotherapy drug, using copper oxide nanostructured films in a photoelectrocatalytic process assisted by hydrogen peroxide. The study identifies the by-products formed during degradation and assesses their toxicity. The research highlights the potential of CuO nanostructured films in environmental remediation and pharmaceutical waste management (da Rosa et al., 2019).
  • Analysis Note: Assay (complexometric): ≥ 99.0 %Substances insoluble in dilute hydrochloric acid: ≤ 0.02 %Free Alkali: passes testChloride (Cl): ≤ 0.005 %Total sulfur (as SO₄): ≤ 0.01 %Total nitrogen (N): ≤ 0.002 %C (Carbon): ≤ 0.01 %Ca (Calcium): ≤ 0.01 %Cr (Chromium): ≤ 0.05 %Fe (Iron): ≤ 0.05 %K (Potassium): ≤ 0.02 %Na (Sodium): ≤ 0.05 %Pb (Lead): ≤ 0.05 %Particle size (laser diffraction) (d95): ≤ 160 µm
  • Legal Information: EMSURE is a registered trademark of Merck KGaA, Darmstadt, Germany

SAFETY INFORMATION

Pictograms

GHS09

Signal Word

Warning

Hazard Statements

H410

Precautionary Statements

P273 - P391 - P501

Hazard Classifications

Aquatic Acute 1 - Aquatic Chronic 1

Storage Class Code

13 - Non Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable